Eric Rubin, MD, Discusses How the AACR Contributes to Advances for Patients

AACR membership includes scientists and physicians from across the cancer research enterprise. Whether basic, translational, or clinical researchers, they all share the same goal: to make progress for patients. In this post, Eric Rubin, MD, deputy editor of Clinical Cancer Research, one of the AACR’s eight journals, shares his thoughts on the AACR’s role in developing breakthrough cancer treatments.

Read More

Kenneth C. Anderson, MD, Discusses How the AACR Benefits Clinicians

Over the years, clinical research has become an integral part of the American Association for Cancer Research’s meetings and journals. We asked physician-scientist Kenneth C. Anderson, MD, editor-in-chief of Clinical Cancer Research, one of the AACR’s eight journals, to share what the AACR means to him, where the organization is going, and why clinicians like him should be involved.

Read More

Mastering the Clinical Development of Personalized Cancer Medicines

A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have been announced, and in some cases initiated, over the past few …

Read More

New Findings Open Doors for Rational Lung Cancer Treatment Strategies

ALK with crizotinib

In a study published Tuesday in the American Association for Cancer Research’s journal Clinical Cancer Research, researchers identified two novel mutations that cause resistance to alectinib, a drug that belongs …

Read More